Hemochromatosis

Clinics in Liver Disease

Volumn 4, Issue 1, 2000, Pages 211-228

  Powell, Lawrie W ^a   Yapp, Thomas R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ANALYSIS; HEMOCHROMATOSIS; HEPATITIS C; HEREDITY; HISTOPATHOLOGY; HUMAN; IRON OVERLOAD; LABORATORY DIAGNOSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROGNOSIS; REVIEW; STEATOSIS;

EID: 0034424757     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70104-5     Document Type: Article

References (92)

1. Screening blood donors for hereditary hemochromatosis
2. Clinical presentation of hemochromatosis: A changing scene
3. Structure and dynamics of the iron responsive element RNA: Implications for binding of the RNA by iron regulatory binding proteins
4. Decreased CD8-p561ck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis
5. Molecular medicine and hemochromatosis: At the crossroads
6. Hereditary iron overload and African Americans
7. HLA typing in idopathic hemochromatosis: Distinction between homozygotes and heterozygotes with biochemical expression
8. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers
9. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
10. Porphyria cutanea tarda and HLA-linked hemochromatosis: Evidence against a systematic association
11. Mutational analysis in hereditary hemochromatosis
12. Genetic irony beyond haemochromatosis: Clinical effect of HLA-H mutations
13. Putting a hold on "HLA-H."
14. Genetic and phenotype expression of haemochromatosis in Canadians
15. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases
16. A genotypic study of 207 unrelated probands diagnosed as "genetic hemochromatosis" on classical phenotypic criteria
17. Juvenile and adult hemochromatosis are distinct genetic disorders
18. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients
19. Internal regulation of iron absorption
20. The absorption of food iron and inorganic iron by normal, iron-deficient and hemochromatotic subjects
21. Iron absorption
22. Hepatocelullar carcinoma in Italian patients with cirrhosis
23. Expression of HLA-linked hemochromatosis in homozygous and heterozygous subjects for the C 282Y mutation
24. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene
25. The hemochromatosis 845 G- and 187 C-G mutations: Prevalence in non-Caucasian populations
26. Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees
27. Iron-59 absorption measurements by whole body counting studies in alcoholic cirrhosis, hemochromatosis and pancreatitis
28. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
29. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients
30. Familial iron overload with possible autosomal dominant inheritance
31. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
32. HLA-linked haemochromatosis in sporadic porphyria cutanea tarda
33. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis
34. Microcytic anaemia mice have a mutation in Nramp 2, a candidate iron transporter gene
35. Mechanisms of increased iron absorption in murine model of hereditary hemochromatosis: Increased duodenal expression of the iron transporter DMT 1
36. Survival and development of hepatocellular carcinoma (HCC) in genetic hemochromatosis (GH)
37. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies
38. Evidence for altered matrix metalloproteinase and TIMP- 1 activity in genetic hemochromatosis
39. Increased hepatic iron in nonalcoholic steatohepatitis is associated with increased fibrosis
40. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
41. Noninvasive prediction of fibrosis in C 282Y homozygous hemochromatosis
42. Excess iron induces hepatic transforming growth factor Beta 1 in genetic hemochromatosis: Role of oxidative stress
43. Haemochromatosis and HLA-H
44. Localization of the hemochromatosis gene close to D 6S105
45. Haemochromatosis and HLA-H
46. Heterozygosity for HLA-linked haemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda
47. Prevalence of haemochromatosis amongst asymptomatic Australians
48. Hemosiderosis in cirrhosis: A study of 447 native livers
49. The distribution of transferrin saturation in an asymptomatic Australian population: Relevance to the early diagnosis of hemochromatosis
50. Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis
51. Global prevalence of putative haemochromatosis mutations
52. Phenotypic expression of the HLA-linked iron-loading gene in the Afrikaner population of the Western Cape
53. Hereditary haemochromatosis in Denmark 1950-1985: Clinical, biochemical and histological features in 179 patients and 13 preclinical cases
54. Phenotypic expression of HFE mutations: A French study of 1100 unrelated iron-overloaded patients and relatives
55. Long-term survival in patients with hereditary hemochromatosis
56. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis
57. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation
58. Idiopathic haemochromatosis in children. Report of a family
59. Cost-effectiveness of screening for hereditary hemochromatosis
60. Enhanced hepatic collagen type 2 mRNA expression in fat storing cells in a rodent model of hemochromatosis
61. Genetic heterogeneity and genotype/ shphenotype correlations in Italian patients with hemochromatosis
62. Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells
63. Heterogeneity of hemochromatosis in Italy
64. Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality
65. The pathology of the liver in hemochromatosis
66. Serum ferritin levels and hepatocellular carcinoma: The cart or the horse?
67. Primary iron overload
68. Hepatic cirrhosis. A comparison of the four major aetiological groups
69. Hemochromatosis: The impact of early diagnosis and therapy
70. Hepatic stellate cell activation in genetic hemochromatosis: Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
71. Chronic iron overload causes activation of rat lipocytes in vivo
72. Increased frequency of the haemochromatosis Cys 282Tyr mutation in sporadic porphyria cutanea tarda
73. Beta-2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism
74. Iron storage disease
75. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor?
76. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
77. Iron absorption in idiopathic haemochromatosis and its measurement using a whole body counter
78. Kupffer cell iron overload induced intercellular adhesion molecule- 1 expression on hepatocytes in genetic hemochromatosis
79. Isolation of CA dinucleotide repeats close to D6S105; linkage disequilibrium with haemochromatosis
80. Epidemiological clinical spectrum and prognosis of hemochromatosis
81. Endocrine abnormalities in HC
82. The C282Y mutation in haemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients
83. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index
84. The UK Haemochromatosis Consortium: A simple genetic test identifies 90% of UK patients with haemochromatosis
85. Uber Hamochromatose
86. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse
87. Serum ferritin concentration and iron stores in normal subjects
88. Iron absorption and siderosis in chronic liver disease
89. The ancestral haplotype for haemochromatosisfrequency of putative haemochromatosis mutations and iron overload
90. Increased expression of the duodenal metal transporter NRAMP- 2 in patients with hereditary hemochromatosis